Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial.
Untch M, Eidtmann H, du Bois A, Meerpohl HG, Thomssen Ch, Ebert A, Harbeck N, Jackisch C, Heilman V, Emons G, Wallwiener D, Wiese W, Blohmer JU, Höffken K, Kuhn W, Reichardt P, Muscholl M, Pauschinger M, Langer B, Lück HJ. Untch M, et al. Among authors: hoffken k. Eur J Cancer. 2004 May;40(7):988-97. doi: 10.1016/j.ejca.2004.01.011. Eur J Cancer. 2004. PMID: 15093573 Clinical Trial.
Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancer.
Sayer HG, Schilling K, Vogt T, Blumenstengel K, Issa MC, Mügge LO, Kasper C, Kath R, Höffken K. Sayer HG, et al. Among authors: hoffken k. J Cancer Res Clin Oncol. 2003 Jun;129(6):361-6. doi: 10.1007/s00432-003-0449-3. Epub 2003 Jun 18. J Cancer Res Clin Oncol. 2003. PMID: 12884031 Clinical Trial.
[High dose chemotherapy of solid tumors].
Höffken K, Kath R, Fricke HJ, Blumenstengel K, Vogel W, Sayer HG. Höffken K, et al. Med Klin (Munich). 1997 Jul 15;92(7):410-4. doi: 10.1007/BF03042572. Med Klin (Munich). 1997. PMID: 9324626 Review. German.
Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML).
Ganser A, Heil G, Seipelt G, Hofmann W, Fischer JT, Langer W, Brockhaus W, Kolbe K, Ittel TH, Brack N, Fuhr HG, Knuth P, Höffken K, Bergmann L, Hoelzer D. Ganser A, et al. Among authors: hoffken k. Ann Hematol. 2000 Jan;79(1):30-5. doi: 10.1007/s002770050005. Ann Hematol. 2000. PMID: 10663618 Clinical Trial.
221 results